Application 089976
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | THEOPHYLLINE | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A089976-001 | THEOPHYLLINE | THEOPHYLLINE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1995-01-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A089976-001 | THEOPHYLLINE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1995-01-04 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Theophylline | THEOPHYLLINE | Zydus Lifesciences Limited | 7339f98d-b996-4e20-a7a7-315fd2a9fa4d | 2024-05-22 | Theophylline THEOPHYLLINE | |
| Theophylline | THEOPHYLLINE | Harman Finochem Limited | 098db8bb-fa9a-4577-b7d9-86caaefc168a | 2024-04-27 | Warnings, Adverse reactions | Theophylline THEOPHYLLINE |
| Theophylline | THEOPHYLLINE | Bionpharma Inc., | 63517422-45a0-4e78-8505-eca054068ee9 | 2023-10-12 | Warnings, Adverse reactions | Theophylline THEOPHYLLINE |
| Theophylline | THEOPHYLLINE | Camber Pharmaceuticals, Inc. | bf320619-c53b-49a7-97b5-cd0c075a9f75 | 2023-09-20 | Warnings, Adverse reactions | Theophylline THEOPHYLLINE |
| Theophylline | THEOPHYLLINE | Alembic Pharmaceuticals Limited | 31f3c720-1597-4d43-9296-33017b90b15f | 2023-01-11 | Warnings, Adverse reactions | Theophylline THEOPHYLLINE |
| Theophylline | THEOPHYLLINE | Teva Pharmaceuticals, Inc. | 25eabefa-518b-4030-9b72-01ac8b3deba9 | 2022-04-01 | Warnings, Adverse reactions | Theophylline THEOPHYLLINE |
| Theophylline | THEOPHYLLINE | Alembic Pharmaceuticals Inc. | 77e849b8-900b-4f0d-ac5c-1391abcd5721 | 2021-10-01 | Warnings, Adverse reactions | Theophylline THEOPHYLLINE |